All enterprises actively carry out safety education for employees
Release time:
2021-11-11
10# May 31
, Yunnan Jianfeng organized all employees, foreign workers and mine personnel to carry out safety education activities for all employees in two batches. The content includes two major contents: "Typical Violations" and "Key Points of Safety Management Regulations for Accident-prone Operations in Cement Enterprises", which are delivered by General Manager Liu Shenghua. Deputy General Manager Tan Guojian carries out supplementary education from violations found in daily inspections, so that employees can receive profound education. In the follow-up, Yunnan peak will also organize a closed-book examination for all staff, and re-educate and wait for seven days for those who fail the examination. At the same time, according to the different posts, continue to carry out targeted post safety operation procedures training and emergency disposal plan training, etc., effectively curb the signs of accidents.Daye Peak has specially set up a safety and health lecture hall to cover the safety and health education of all employees. The first stage of safety education has been started on December , November
. The safety and health lecture hall will be held in three stages. In the first stage, Zhang Fengliang, deputy general manager of the Group Company, Zhang Fengliang, general manager of Daye Peak, and Tao Yecheng, deputy general manager of Daye Peak, will give lectures respectively. The main focus will be on learning the spirit of the Group Company's document37 , conducting safety operation training, and teaching "Typical Violations 50 ", "," Key Points of Safety Management Regulations for High Incidents in Cement Enterprise Accidents "and" and "and" and "Accidents. In the second stage, the department will mainly conduct training. The department head will conduct training on "Typical Violations 50 " and "Key Points of Safety Management Regulations for High Accident Operation in Cement Enterprises" for each employee again. Carry out the study of post operation procedures and safety operation procedures; Combined with the company's accident case library and the actual work at this stage, carry out the analysis of typical accident cases. The third stage is the responsibility of EHS Dept., which mainly refers to the training contents of the first two stages to train the resident outsourcing units. At the same time, in order to improve the effectiveness of training, Daye Peak requires all staff to understand and master the specific performance of illegal operations, the harmfulness and possible consequences of illegal operations. Each department organizes employees to carry out accident case analysis, analyze illegal operations and reasons, summarize lessons and make on-site comments, improve employees' ability to identify violations and prevent violations of consciousness; Heads of departments are responsible for on-site testing; EHS Dept. is responsible for spot check and verification of training verification work and conducting written closed-book test for all personnel. In addition, Daye Peak will focus on self-examination and self-correction of violations, hidden danger investigation and on-site violations inspection in the last two months of this year. All employees will sign a safety undertaking, fully implement the safety risk assessment, and severely assess violations. Guizhou Huangping Jianfeng, Cable Company, International Trade Company, Tianjin Jianfeng Natural Products Company and Pharmaceutical Company have also held safety work meetings one after another to analyze the reasons for the specific situation of recent safety production management, learn 50 typical violations, carry out typical accident case analysis, and further implement safety management.
(Qi JianmeiSong Xiaofei Shi Fu
Wang Zhijian Lu Xianhui)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page